Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 265714, 6 pages
http://dx.doi.org/10.1155/2012/265714
Research Article

Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells

Department of Otorhinolaryngology, Shiga University of Medical Science, Seta, Tsukinowa, Otsu, Shiga 520-2192, Japan

Received 16 January 2012; Revised 27 February 2012; Accepted 2 March 2012

Academic Editor: Kazuhito Asano

Copyright © 2012 Takeshi Shimizu and Shino Shimizu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Takeshi Shimizupp. 1–14, 2013. View at PublisherView at Google Scholar
  • Clémence Martin, Justine Frija-Masson, and Pierre-Régis Burgel, “Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD?,” Drugs, 2014. View at PublisherView at Google Scholar
  • Hiroshi Kakeya, Masafumi Seki, Koichi Izumikawa, Kosuke Kosai, Yoshitomo Morinaga, Shintaro Kurihara, Shigeki Nakamura, Yoshifumi Imamura, Taiga Miyazaki, Misuzu Tsukamoto, Katsunori Yanagihara, Takayoshi Tashiro, and Shigeru Kohno, “Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study,” Plos One, vol. 9, no. 3, 2014. View at PublisherView at Google Scholar
  • Orapan Poachanukoon, Sittichai Koontongkaew, Paopanga Monthanapisut, and Napaporn Pattanacharoenchai, “Macrolides Attenuate Phorbol Ester-Induced Tumor Necrosis Factor-alpha and Mucin Production from Human Airway Epithelial Cells,” Pharmacology, vol. 93, no. 1-2, pp. 92–99, 2014. View at PublisherView at Google Scholar
  • Abely, Jubin, Bessaci-Kabouya, Chiron, Bui, and Fayon, “National consensus regarding azithromycin use in cystic fibrosis,” Revue des Maladies Respiratoires, vol. 32, no. 6, pp. 557–565, 2015. View at PublisherView at Google Scholar
  • M. Abely, V. Jubin, K. Bessaci-Kabouya, R. Chiron, S. Bui, and M. Fayon, “Consensus national sur la prescription de l’azithromycine dans la mucoviscidose,” Revue des Maladies Respiratoires, 2015. View at PublisherView at Google Scholar
  • Ichiro Tojima, Shino Shimizu, Takao Ogawa, Hideaki Kouzaki, Satoshi Omura, Toshiaki Sunazuka, and Takeshi Shimizu, “Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium,” Auris Nasus Larynx, 2015. View at PublisherView at Google Scholar
  • Emily V. S. Ha, and Duncan F. Rogers, “Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases,” Pharmacology, vol. 97, no. 1-2, pp. 84–100, 2016. View at PublisherView at Google Scholar
  • Krishna Bajee Sriram, Amanda J. Cox, Robert L. Clancy, Mary P. E. Slack, and Allan W. Cripps, “ Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians ,” Critical Reviews in Microbiology, vol. 44, no. 2, pp. 125–142, 2017. View at PublisherView at Google Scholar